Sign In
Buy CKPT
$4.26
+0 (+0%)
At Close: Aug 29, 2025
Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market
12:33pm, Wednesday, 20'th May 2020
The following article is sponsored by the clinical communications unit of investor relations firm Redington, Inc. The information contained in this article in no way represents investment advice or op
Li Ka-shing’s CK Asset Sounds Profit Alarm as COVID-19 Crimps Business
10:19am, Sunday, 17'th May 2020
The property conglomerate chaired by the son of Hong Kong’s richest man has warned shareholders
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
12:41pm, Saturday, 09'th May 2020
A week ago, Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) came out with a strong set of quarterly numbers that could...
Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
08:30pm, Wednesday, 06'th May 2020
NEW YORK, May 06, 2020 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company focused on the acquisition,.
NEW YORK, April 27, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Checkpoint.
Is Checkpoint Therapeutics (NASDAQ:CKPT) In A Good Position To Invest In Growth?
10:52am, Monday, 27'th Apr 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody Cosibelimab
12:00pm, Tuesday, 21'st Apr 2020
- U.S. patent protection through at least May 2038- Registration-enabling study of cosibelimab in cutaneous squamous cell carcinoma over one-third enrolled NEW YORK, April 21,.
Agenus At The Time Of The Coronavirus
07:30pm, Thursday, 02'nd Apr 2020
Agenus has a broad and deep pipeline into clinical development. The company is running two pivotal trials. AGEN1181 may have best in class properties that could
Financial Comparison: ProQR Therapeutics (NASDAQ:PRQR) versus Checkpoint Therapeutics (NASDAQ:CKPT)
05:54am, Sunday, 15'th Mar 2020
ProQR Therapeutics (NASDAQ:PRQR) and Checkpoint Therapeutics (NASDAQ:CKPT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strengt
Checkpoint Therapeutics, Inc. Just Reported And Analysts Have Been Lifting Their Price Targets
11:04am, Friday, 13'th Mar 2020
There's been a major selloff in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) shares in the week since it released its...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
08:15pm, Wednesday, 11'th Mar 2020
NEW YORK, March 11, 2020 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition,.
Have Insiders Been Buying Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares?
11:31am, Monday, 02'nd Mar 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Checkpoint Therapeutics: Beat The System
08:59pm, Friday, 21'st Feb 2020
CKPT expects to submitt a BLA for cosibelimab in 2021. CK-101 data update is expected in early 2020. The possibility of fast approval justifies the decision to
Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that feedback from the U.S. Food and Drug Administration (“FDA�
